{
    "clinical_study": {
        "@rank": "92598", 
        "arm_group": [
            {
                "arm_group_label": "foley bulb induction with low dose pitocin", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes."
            }, 
            {
                "arm_group_label": "foley bulb with standard incremental pitocin infusion protocol", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this research study is to compare induction of labor using a foley catheter\n      bulb with a low dose of oxytocin versus a foley catheter bulb with an increasing dose of\n      oxytocin.  A foley catheter bulb with or without oxytocin is a common method of labor\n      induction in patients whose cervix is not significantly dilated or thinned out (effaced).\n      Oxytocin (pitocin) is a medicine used to increase the number and strength of the womb's\n      contractions."
        }, 
        "brief_title": "Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor", 
        "completion_date": {
            "#text": "March 2009", 
            "@type": "Actual"
        }, 
        "condition": "Induction of Labor", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients with a singleton pregnancy\n\n          2. Term pregnancy (> 37 weeks gestation)\n\n          3. Age \u2265  18 years\n\n          4. Bishop score < 5\n\n          5. Contractions < 6/hr\n\n          6. Reassuring fetal heart tracing\n\n        Exclusion Criteria:\n\n          1. Rupture of membranes\n\n          2. Antepartum bleeding\n\n          3. Fetal death\n\n          4. Placenta previa or low lying placenta\n\n          5. Active genital herpes infection\n\n          6. Previous use of an induction or preinduction agent during the current pregnancy\n\n          7. EFW >4500 grams\n\n          8. Non reassuring fetal testing\n\n          9. Inability to pass foley through cervix\n\n         10. Prior cesarean section"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "121", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02150954", 
            "org_study_id": "Pro00001312"
        }, 
        "intervention": {
            "arm_group_label": [
                "foley bulb induction with low dose pitocin", 
                "foley bulb with standard incremental pitocin infusion protocol"
            ], 
            "intervention_name": "pitocin", 
            "intervention_type": "Drug", 
            "other_name": "oxytocin"
        }, 
        "intervention_browse": {
            "mesh_term": "Oxytocin"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "induction of labor", 
            "pitocin", 
            "foley bulb"
        ], 
        "lastchanged_date": "May 27, 2014", 
        "number_of_arms": "2", 
        "official_title": "A Randomized Comparison of Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor", 
        "overall_official": [
            {
                "affiliation": "Duke University", 
                "last_name": "Chad Grotegut, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Duke University", 
                "last_name": "Brennan Fitzpatrick, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "time to the second stage of labor", 
                "safety_issue": "No", 
                "time_frame": "foley bulb placement until second stage of labor (during admission for delivery, up to approximately 4 days)"
            }, 
            {
                "measure": "time to delivery", 
                "safety_issue": "No", 
                "time_frame": "foley bulb placement until delivery (during admission for delivery, up to approximately 4 days)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02150954"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "rate of cesarean delivery", 
                "safety_issue": "No", 
                "time_frame": "during admission for delivery, up to approximately 4 days"
            }, 
            {
                "measure": "time to active labor", 
                "safety_issue": "No", 
                "time_frame": "during admission for delivery, up to approximately 4 days"
            }, 
            {
                "measure": "time to foley expulsion or removal", 
                "safety_issue": "No", 
                "time_frame": "foley bulb placement until removal, up to 10 hours"
            }, 
            {
                "measure": "incidence of uterine hyperstimulation", 
                "safety_issue": "No", 
                "time_frame": "during admission for delivery, up to approximately 4 days"
            }, 
            {
                "measure": "neonatal outcome", 
                "safety_issue": "No", 
                "time_frame": "during admission for delivery, up to approximately 4 days"
            }
        ], 
        "source": "Duke University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Duke University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2007", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}